When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.
Be alerted of any news about your stocks and see what other stocks are trending.
OMER - FDA on board with endpoint for pivot study of Omeros' narsoplimab; shares up 12% premarket
Omeros Corporation
Omeros (NASDAQ:OMER) is up 12% premarket on modest volume on the heels of its announcement that the FDA has agreed on the primary endpoint for its pivotal study evaluating lead candidate narsoplimab (OMS721) for the treatment of hematopoietic stem cell transplant-associated thrombotic microangiopathy (HSCT-TMA), a Breakthrough Therapy-tagged indication.
More news on: Omeros Corporation, Healthcare stocks news, Stocks on the move,